181697-29-0

Basic information

• Product Name: 1-(3-chlorophenyl)-2-phenyl-ethan-1-one oxime
• Synonyms: 1-(3-chlorophenyl)-2-phenyl-ethan-1-one oxime
• CAS NO: 181697-29-0
• Molecular Weight: 245.708
• Mol File: 181697-29-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-(3-chlorophenyl)-2-phenyl-ethan-1-one oxime(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-chlorophenyl)-2-phenyl-ethan-1-one oxime(181697-29-0)
• EPA Substance Registry System: 1-(3-chlorophenyl)-2-phenyl-ethan-1-one oxime(181697-29-0)

Safety Data

• Hazardous Substances Data: 181697-29-0(Hazardous Substances Data)

Upstream product

• 63503-60-6 3-chlorophenylboronic acid 
• 140-29-4 phenylacetonitrile 
• 587-04-2 m-Chlorobenzaldehyde 
• 100-39-0 benzyl bromide 
• 62482-45-5 1-(m-chlorophenyl)-2-phenylethanone 

Downstream Products

• 181696-19-5 4-[3-(3-chlorophenyl)-5-methylisoxazol-4-yl]benzenesulfonamide 

Relevant articles and documents

Visible-Light-Promoted [3 + 2] Cycloaddition of 2H-Azirines with Quinones: Access to Substituted Benzo[f]isoindole-4,9-diones

A visible-light-promoteded [3 + 2] cycloaddition reaction of 2H-azirines with quinones has been developed under mild reaction conditions. The reaction provides a general and efficient strategy for the synthesis of the benzo[f]isoindole-4,9-diones scaffold

Zinc-Enabled Annulation of Trifluorodiazoethane with 2 H-Azirines to Construct Trifluoromethyl Pyrazolines, Pyrazoles, and Pyridazines

A diethylzinc-promoted unconventional annulation reaction of 2,2,2-trifluorodiazoethane with 2H-azirines is described. This transformation involves two [3 + 2] cycloaddition steps and one dinitrogen extrusion process in one pot, thus giving a broad array

Substituted isoxazoles for the treatment of inflammation

A class of substituted isoxazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula (III) wherein R7 is selected from hydroxyl, lower alkyl, carboxyl, halo, lower carboxylalkyl, lower alkoxycarbonylalkyl, lower alkoxyalkyl, lower carboxyalkoxyalkyl, lower haloalkyl, lower haloalkylsulfonyloxy, lower hydroxyalkyl, lower aryl (hydroxylalkyl), lower carboxyaryloxyalkyl, lower alkoxycarbonylaryloxyalkyl, lower cycloalkyl, lower cycloalkylalkyl, and lower aralkyl; and wherein R8 is one or more radicals independently selected from hydrido, lower alkylsulfinyl, lower alkyl, cyano, carboxyl, lower alkoxycarbonyl, lower haloalkyl, hydroxyl, lower hydroxyalkyl, lower haloalkoxy, amino, lower alkylamino, lower arylamino, lower aminoalkyl, nitro, halo, lower alkoxy, aminosulfonyl, and lower alkylthio; or a pharmaceutically-acceptable salt thereof.